Chonluten — EU research guide.
Chonluten is a synthetic tripeptide (Glu-Asp-Gly) from the Khavinson bioregulator series targeting bronchopulmonary tissue broadly, including mucosal and lung-function markers. It is often discussed alongside Bronchogen and Taxorest as part of an Eastern European respiratory-support protocol, though the three target slightly different aspects of lung tissue.
What is Chonluten?
Chonluten is a synthetic tripeptide (Glu-Asp-Gly) from the Khavinson bioregulator series targeting bronchopulmonary tissue broadly, including mucosal and lung-function markers. It is often discussed alongside Bronchogen and Taxorest as part of an Eastern European respiratory-support protocol, though the three target slightly different aspects of lung tissue.
What does the research show?
Reported effects center on lung function and mucosal-health markers in animal studies and small human cohorts from the originating research group. No large independently replicated trials are publicly available as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Sold by a small number of specialist research vendors for laboratory use only.
Molecular information
Pharmacokinetics
Chonluten is not yet in our price comparison
We expand EU supplier coverage every month.